Chandrakesan Parthasarathy, Yao Jiannan, Qu Dongfeng, May Randal, Weygant Nathaniel, Ge Yang, Ali Naushad, Sureban Sripathi M, Gude Modhi, Vega Kenneth, Bannerman-Menson Eddie, Xia Lijun, Bronze Michael, An Guangyu, Houchen Courtney W
Division of Digestive Diseases and Nutrition, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
OU Cancer Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Mol Cancer. 2017 Feb 1;16(1):30. doi: 10.1186/s12943-017-0594-y.
More than 80% of intestinal neoplasia is associated with the adenomatous polyposis coli (APC) mutation. Doublecortin-like kinase 1 (Dclk1), a kinase protein, is overexpressed in colorectal cancer and specifically marks tumor stem cells (TSCs) that self-renew and increased the tumor progeny in Apc mice. However, the role of Dclk1 expression and its contribution to regulating pro-survival signaling for tumor progression in Apc mutant cancer is poorly understood.
We analyzed DCLK1 and pro-survival signaling gene expression datasets of 329 specimens from TCGA Colon Adenocarcinoma Cancer Data. The network of DCLK1 and pro-survival signaling was analyzed utilizing the GeneMANIA database. We examined the expression levels of Dclk1 and other stem cell-associated markers, pro-survival signaling pathways, cell self-renewal in the isolated intestinal epithelial cells of Apc mice with high-grade dysplasia and adenocarcinoma. To determine the functional role of Dclk1 for tumor progression, we knocked down Dclk1 and determined the pro-survival signaling pathways and stemness. We used siRNA technology to gene silence pro-survival signaling in colon cancer cells in vitro. We utilized FACS, IHC, western blot, RT-PCR, and clonogenic (self-renewal) assays.
We found a correlation between DCLK1 and pro-survival signaling expression. The expression of Dclk1 and stem cell-associated markers Lgr5, Bmi1, and Musashi1 were significantly higher in the intestinal epithelial cells of Apc mice than in wild-type controls. Intestinal epithelial cells of Apc mice showed increased expression of pro-survival signaling, pluripotency and self-renewal ability. Furthermore, the enteroids formed from the intestinal Dclk1 cells of Apc mice display higher pluripotency and pro-survival signaling. Dclk1 knockdown in Apc mice attenuates intestinal adenomas and adenocarcinoma, and decreases pro-survival signaling and self-renewal. Knocking down RELA and NOTCH1 pro-survival signaling and DCLK1 in HT29 and DLD1 colon cancer cells in vitro reduced the tumor cells' ability to self-renew and survive.
Our results indicate that Dclk1 is essential in advancing intestinal tumorigenesis. Knocking down Dclk1 decreases tumor stemness and progression and is thus predicted to regulate pro-survival signaling and tumor cell pluripotency. This study provides a strong rationale to target Dclk1 as a treatment strategy for colorectal cancer.
超过80%的肠道肿瘤形成与腺瘤性息肉病基因(APC)突变有关。双皮质素样激酶1(Dclk1)是一种激酶蛋白,在结直肠癌中过表达,并特异性标记自我更新的肿瘤干细胞(TSCs),且在Apc小鼠中增加肿瘤子代细胞数量。然而,对于Dclk1表达在Apc突变型癌症肿瘤进展中调节促生存信号传导的作用及其贡献,人们了解甚少。
我们分析了来自TCGA结肠腺癌数据的329个样本的DCLK1和促生存信号基因表达数据集。利用GeneMANIA数据库分析DCLK1和促生存信号的网络。我们检测了Apc小鼠高级别发育异常和腺癌的分离肠上皮细胞中Dclk1和其他干细胞相关标志物、促生存信号通路、细胞自我更新的表达水平。为了确定Dclk1对肿瘤进展的功能作用,我们敲低Dclk1并确定促生存信号通路和干性。我们使用小干扰RNA(siRNA)技术在体外使结肠癌细胞中的促生存信号基因沉默。我们采用了荧光激活细胞分选(FACS)、免疫组化(IHC)、蛋白质免疫印迹法(western blot)、逆转录-聚合酶链反应(RT-PCR)和克隆形成(自我更新)分析。
我们发现DCLK1与促生存信号表达之间存在相关性。Apc小鼠肠上皮细胞中Dclk1和干细胞相关标志物Lgr5、Bmi1和Musashi1的表达明显高于野生型对照。Apc小鼠的肠上皮细胞显示促生存信号、多能性和自我更新能力增强。此外,由Apc小鼠的肠Dclk1细胞形成的类器官显示出更高的多能性和促生存信号。敲低Apc小鼠中的Dclk1可减轻肠道腺瘤和腺癌,并降低促生存信号和自我更新。在体外敲低HT29和DLD1结肠癌细胞中的RELA和NOTCH1促生存信号以及DCLK1可降低肿瘤细胞的自我更新和存活能力。
我们的结果表明,Dclk1在推进肠道肿瘤发生过程中至关重要。敲低Dclk1可降低肿瘤干性和进展,因此预计其可调节促生存信号和肿瘤细胞多能性。本研究为将Dclk1作为结直肠癌的治疗策略提供了有力依据。